NCT05531656Phase 2Active not recruiting

A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

Study sponsor: Cognition Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-05-31Estimated
Enrollment · participants540Estimated
Source updated2026-08-10Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Apr 2027. After: 31 May 2027.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview